Your browser doesn't support javascript.
loading
Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.
Winham, Stacey J; Pirie, Ailith; Chen, Yian Ann; Larson, Melissa C; Fogarty, Zachary C; Earp, Madalene A; Anton-Culver, Hoda; Bandera, Elisa V; Cramer, Daniel; Doherty, Jennifer A; Goodman, Marc T; Gronwald, Jacek; Karlan, Beth Y; Kjaer, Susanne K; Levine, Douglas A; Menon, Usha; Ness, Roberta B; Pearce, Celeste L; Pejovic, Tanja; Rossing, Mary Anne; Wentzensen, Nicolas; Bean, Yukie T; Bisogna, Maria; Brinton, Louise A; Carney, Michael E; Cunningham, Julie M; Cybulski, Cezary; deFazio, Anna; Dicks, Ed M; Edwards, Robert P; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Gore, Martin; Iversen, Edwin S; Jensen, Allan; Johnatty, Sharon E; Lester, Jenny; Lin, Hui-Yi; Lissowska, Jolanta; Lubinski, Jan; Menkiszak, Janusz; Modugno, Francesmary; Moysich, Kirsten B; Orlow, Irene; Pike, Malcolm C; Ramus, Susan J; Song, Honglin; Terry, Kathryn L; Thompson, Pamela J; Tyrer, Jonathan P.
Afiliação
  • Winham SJ; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Pirie A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Chen YA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Larson MC; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Fogarty ZC; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Earp MA; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California.
  • Bandera EV; Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
  • Doherty JA; Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
  • Goodman MT; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Karlan BY; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Kjaer SK; Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Menon U; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Ness RB; The University of Texas School of Public Health, Houston, Texas.
  • Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Pejovic T; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon. Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Rossing MA; Department of Epidemiology, University of Washington, Seattle, Washington. Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Wentzensen N; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Bean YT; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon. Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Brinton LA; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Carney ME; Department of Obstectrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
  • Cunningham JM; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota.
  • Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical Academy, Szczecin, Poland.
  • deFazio A; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia. Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia.
  • Dicks EM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
  • Edwards RP; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Gentry-Maharaj A; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Gore M; Gynecological Oncology Unit, The Royal Marsden Hospital, London, United Kingdom.
  • Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina.
  • Jensen A; Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Johnatty SE; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Lester J; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Lin HY; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
  • Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Menkiszak J; Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
  • Modugno F; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania. Womens Cancer Res
  • Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Song H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
  • Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
  • Thompson PJ; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Tyrer JP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Cancer Epidemiol Biomarkers Prev ; 25(3): 446-54, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26747452

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos